Drug Shortage Report for SODIUM BICARBONATE INJECTION, USP

Last updated on 2020-12-01 History
Report ID 128660
Drug Identification Number 02486636
Brand name SODIUM BICARBONATE INJECTION, USP
Common or Proper name Sodium Bicarbonate Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) SODIUM BICARBONATE
Strength(s) 84MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 8.4%, 50 mEq (mmol), 50 mL Vial
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-11-30
Actual start date
Estimated end date 2021-01-04
Actual end date
Shortage status Actual shortage
Updated date 2020-12-01
Company comments Fresenius Kabi Canada Ltd. regrets to advise that due to a production delay, we will be encountering a supply interruption on our Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq (mmol), 50 mL Vial. We expect to be on backorder from November 30, 2020 to January 4, 2021. The product will remain on 100% allocation until stock is depleted.
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2020-12-01 English Compare
v2 2020-11-20 French Compare
v1 2020-11-20 English Compare